NeuroICH

by Neurocareai Inc.  · Based in United States → — A Global Healthcare AI Factory — Agentic Multimodal Intelligence, Synergistically Transforming Care.
Emergency Medicine Neurology Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

NeuroICH, developed by Neurocareai Inc. (operating as SaveLife.AI), is an artificial intelligence software tool designed for the rapid detection and triage of suspected intracranial hemorrhage (ICH). The tool analyzes non-contrast head CT scans to identify potential cases of ICH, assisting clinical teams in prioritizing urgent cases.

The software is primarily designed for emergency medicine physicians, radiologists, and neurologists operating in acute care settings, such as emergency departments and stroke centers. By flagging suspected ICH cases, it helps streamline the clinical workflow during critical, time-sensitive patient evaluations.

NeuroICH integrates into existing hospital workflows through the platform’s ConnectAI gateway, which connects with major PACS and EHR systems. Notable capabilities of the tool include:

  • Automated analysis of head CT scans to detect intracranial hemorrhage.
  • Rapid processing times, designed to flag suspected cases in under 60 seconds.
  • Seamless integration with DICOM-compliant imaging systems and PACS.
  • Support for acute stroke workflows by facilitating faster triage of critical imaging results to on-call specialists.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Detects intracranial hemorrhages
  • Rapid and accurate identification of hemorrhages
  • Computer-assisted diagnostic (CAD) tool
  • Notification-only, parallel workflow tool
  • Analyzes non-contrast CT images of the head
  • Empowers timely clinical decisions
  • Improves patient outcomes in critical care scenarios
  • Mobile application for preview of notification and non-diagnostic images
  • Cloud-hosted image analysis module

Use Cases

  • Detecting intracranial hemorrhages in acute settings
  • Assisting healthcare professionals in critical care scenarios
  • Rapid identification of suspected ICH patients
  • Communicating images of suspected ICH patients to specialists
  • Enhancing acute stroke care
  • Reducing latency in stroke treatment

What Physicians Need to Know

Stroke Detection Speed
NeuroICH provides rapid and accurate identification of potential intracranial hemorrhages (ICH) from non-contrast CT scans, enabling timely clinical decisions.
Brain MRI/CT Analysis
The tool utilizes an advanced artificial intelligence algorithm to analyze non-contrast head CT images for findings suggestive of intracranial hemorrhage (ICH).
Triage Prioritization Speed
NeuroICH functions as a notification-only, parallel workflow tool, identifying and communicating images of suspected ICH patients to specialists, independent of the standard workflow, thereby accelerating triage.
Mobile Notification System
It includes a mobile application that sends instant notifications and non-diagnostic image previews to mobile devices, allowing specialists to review and act quickly.
Physician Tip

NeuroICH is a computer-assisted diagnostic (CAD) tool designed to support, not replace, clinical judgment. Healthcare professionals should always rely on their own clinical assessment and refer to the PACS or hospital's clinical system for comprehensive case evaluation before making any medical decisions. The rapid alerts and non-diagnostic image previews on mobile devices are intended to facilitate quicker communication and decision-making in critical care scenarios, particularly for suspected intracranial hemorrhages.

NeuroICH is a software-only solution that automatically receives and analyzes non-contrast head CT studies from DICOM-compliant imaging devices and modalities. Its image analysis module is cloud-hosted, and it offers a mobile application for reviewing notifications and non-diagnostic images. The system is compatible with DICOM files and supports both centralized and distributed care networks, allowing for real-time navigation and review of patient data from multiple locations.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing — Contact for pricing
DeploymentCloud
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

NeuroICH (K241719) is an FDA-cleared Radiological Computer-Assisted Triage and Notification Software. It is a notification-only, parallel workflow tool for identifying suspected intracranial hemorrhage in non-contrast CT images of the head, with the FDA letter dated November 7, 2024.
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

What the Web Says

NeuroICH by NeuroCare.AI is an AI-powered software designed to rapidly detect intracranial hemorrhages from non-contrast CT scans, aiming to improve patient outcomes in stroke cases. It functions as a notification-only, parallel workflow tool for trained clinicians and has received FDA approval as a Software as a Medical Device (SaMD). The technology is intended to assist healthcare professionals in making timely clinical decisions, not for diagnostic decision-making itself.

Overall: Mixed

Strengths

  • Rapid identification of suspected intracranial hemorrhages.
  • Aids in timely clinical decisions for stroke patients.
  • Aims to reduce long-term impacts of strokes.
  • FDA-approved as a Software as a Medical Device (SaMD).
  • Integrates into existing hospital workflows without disruption.
  • Utilizes deep learning AI algorithms for analysis.

Limitations

  • Not intended for diagnostic decision-making; clinicians must rely on their own judgment and PACS.
  • Limited public reviews available from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
  • Mobile app has not received enough ratings or reviews to display an overview.
  • No specific reviews found from Reddit, G2, or Capterra for NeuroICH.
  • Some general concerns about the reliability of reviews on platforms like Capterra and G2 exist.

Based on reviews from: Compare NeuroICH vs. Regard in 2026, NeuroICH - App Store, NeuroICHu2122 - Apps on Google Play, NeuroICH - App Store, Re - accessdata.fda.gov, NeuroICHu2122 - Apps on Google Play, Compare NeuroICH vs. Qure.ai in 2026 - Slashdot, Driving AI-Powered Healthcare Innovation: How Segmed Helped NeuroCare.AI Achieve Success | Andru00e9ia Pereira, Neuro Software Pricing, Alternatives & More 2026 - Capterra, Compare BrightInsight vs. NeuroICH in 2026 - Software - Slashdot, Capterra: Find The Right Software, Are G2 reviews reliable? - Quora, Capterra Reviews 2026: Details, Pricing, & Features | G2, Is capterra good? - Quora, Capterra Reviews & Ratings 2026 - TrustRadius, Top 30 Tech YouTubers to Follow for Reviews, News & Gadgets!, G2 Reviews | Read Customer Service Reviews of www.g2.com - Trustpilot, NRx Reviews 2026: Details, Pricing, & Features - G2, N.Rich Reviews 2026: Details, Pricing, & Features | G2, Neuro supplement scam - looking for advice : r/Alzheimers - Reddit, Working at Neurotech, LLC: Employee Reviews | Indeed.com, Working at Healthcare IT: Employee Reviews | Indeed.com, Nuix Neo Discover Reviews 2026: Details, Pricing, & Features | G2, Working at Neurotech, LLC in Schaumburg, IL: Employee Reviews about Management, How NeuroAI Is Changing Brain Diagnostics (And What You Need to Know), Neuro Tech IQ Reviews & Complaints (A +Closer+ Look At The Growing Interest) Side Effects, Ingredients, Official Site [R0DAFDPNG]

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate NeuroICH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Signalbase
NeuroCare.AI Secures $20.8M Funding Boost to Accelerate AI-Driven Healthcare Innovation
NeuroCare.AI announced a $20.8 million funding round to advance its AI-driven healthcare solutions, including NeuroICH for real-time brain scan analysis and early stroke detection. This investment will support the expansion and enhancement of its product suite and global reach.
2025-02
Signify Research
AI in Medical Imaging News Round Up u2013 November 2024
This news roundup mentions that NeuroICH received FDA clearance as an AI-based tool for detecting stroke, among other regulatory approvals in medical imaging. The article highlights advancements in AI for various diagnostic applications.
2024-12
Slashdot
NeuroICH Receives FDA Approval as a Software as a Medical Device (SaMD)
NeuroICH, an AI tool designed to identify cerebral hemorrhages for stroke patients, has recently received FDA approval as a Software as a Medical Device (SaMD). This approval underscores its reliability and effectiveness in clinical settings for rapid evaluation and imaging analysis.
2024-11
Institute of Health Innovation & Education (IHIE.IO)
Revolutionizing AI-Based Stroke Care - IHIE.IO
IHIE.IO, in collaboration with NeuroCareAI, is implementing the NeuroICH AI Model in clinical settings to revolutionize hyperacute stroke care, particularly in Low- and Middle-Income Countries (LMICs). The model boasts an overall accuracy of 98% for ICH detection.
unknown
ResearchGate (European Radiology)
Systematic review of commercial artificial intelligence tools for the detection and volume quantification in intracerebral hemorrhage
This systematic review, published in European Radiology, includes NeuroICH by Neurocareai Inc. as one of the commercial AI tools for intracerebral hemorrhage detection. It notes NeuroICH's FDA 510(K) Class II clearance with application number K241719.
2025-07
Segmed
Driving AI-Powered Healthcare Innovation: How Segmed Helped NeuroCare.AI Achieve Success
This article highlights how Segmed's data solutions accelerated NeuroCare.AI's development and FDA approval for NeuroICH, an AI-powered Software-as-a-Medical-Device (SaMD) for detecting cerebral hemorrhage. Segmed provided diverse, de-identified, and regulatory-compliant medical imaging data.
unknown
Apple App Store
NeuroICH - App Store
The NeuroICH mobile app, developed by NeuroCare.AI, is an advanced AI solution designed to detect intracranial hemorrhages and assist trained healthcare professionals. It is regulated as an FDA-cleared medical device, providing rapid and accurate identification of suspected hemorrhages.
2025-01
APKPure
NeuroChat.AI APK Download for Android - Latest Version - APKPure
NeuroChat.AI, an app by NeuroCare.AI, is presented as a tool for healthcare research, leveraging generative AI and large language models to query and summarize neuroscientific literature. NeuroICH is listed as an alternative or related app by NeuroCare.AI.
2024-03

Videos

Product demos, reviews, and walkthroughs for NeuroICH.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

NeuroICH is an AI-powered software designed to analyze non-contrast CT images of the head to identify findings suggestive of intracranial hemorrhage (ICH). It functions as a notification-only, parallel workflow tool, alerting trained clinicians to suspected ICH cases independently of the standard interpretation process, but it is not intended for diagnostic decision-making.
NeuroICH has received FDA 510(k) clearance, indicating it meets regulatory standards for medical devices. However, physicians must also ensure compliance with data privacy regulations like HIPAA, as AI systems handle sensitive patient data. Ethical considerations, including transparency, patient consent, and accountability for AI-driven decisions, are also paramount.
The gold standard for diagnosing intracranial hemorrhage remains the rapid interpretation of non-contrast CT scans by trained radiologists. For ICH management, alternatives also include traditional conservative medical treatment and various minimally invasive surgical techniques.
Pricing for AI radiology solutions often involves subscription-based models or pay-per-use structures, with costs varying based on customer needs and usage volume. Reimbursement for AI applications in radiology is a critical and evolving area, as prospective payment systems may not adequately cover the additional costs of innovative technologies, often requiring separate consideration for reimbursement.
Limitations of AI in neuroimaging include potential algorithmic bias stemming from unrepresentative training data, which can lead to disparities in care. There are also concerns about the 'black-box' nature of some AI models, making their decision-making process opaque, and the potential for false positives. Some studies suggest AI assistance may not significantly improve radiologists' diagnostic accuracy or turnaround times for ICH.
NeuroICH is designed as a parallel workflow tool, providing notifications of suspected ICH findings without altering the original medical image or standard interpretation process. While AI aims to reduce cognitive and operational burden and streamline workflows, clinicians remain responsible for final diagnostic decisions and patient evaluation.
NeuroICH is FDA-cleared, indicating it has met specific performance criteria. Other AI models for ICH detection have demonstrated high sensitivity and specificity in identifying various hemorrhage subtypes. However, physicians should be aware that AI is not infallible, and its real-world effectiveness can vary, with some studies showing radiologists still significantly outperform standalone AI services in diagnostic accuracy.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Paid
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.